Asceneuron – Talk Bio

Actionable Insights Powered by AI

Asceneuron Secures $100 Million in Series C Funding for Dementia Asset Development

9 months ago talkbio0Tagged Asceneuron, asset, biotech, Investments, Presenile dementia, Series C, Ventures

Asceneuron, Series C Funding, Dementia Asset, Novo Ventures, Biotech Investment